Live
ePaper
Search
Home > India > BRIEF-Natco Pharma Receives EIR From U.S. FDA For FDF Unit

BRIEF-Natco Pharma Receives EIR From U.S. FDA For FDF Unit

Written By:
Last Updated: November 20, 2026 08:35:39 IST

Nov 20 (Reuters) – Natco Pharma Ltd: * NATCO PHARMA – RECEIVES EIR FROM U.S. FDA FOR FDF UNIT * NATCO PHARMA – COMPANY RECEIVED 4 OBSERVATIONS IN FORM-483 AT FDA INSPECTION CONCLUSION * NATCO PHARMA –

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?